According to the government, these providers submitted false claims to MassHealth for urine drug tests and home health services.
The firm said that a strong start to the commercialization of its Liaison Plex platform also aided growth in its molecular diagnostics business.
The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.
The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.
The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback